Ozempic Breath Is on the Rise—and So Is This Unlikely Winner
The rise in use of GLP-1 drugs like Ozempic and Wegovy has been linked to an increase in cases of bad breath, colloquially known as "Ozempic breath," due to factors such as dehydration and reduced saliva flow. In response, sales of breath-freshening products like Ice Breakers gum have risen, with Hershey reporting an 8% increase in the brand's retail sales in early 2026. Experts recommend staying hydrated and using sugar-free gum to mitigate oral health issues, though increased water intake remains the most effective preventive measure.
Opening excerpt (first ~120 words) tap to expand
Ozempic, Wegovy, and other GLP-1 weight loss drugs are doing some pretty gross things to people’s mouths—an unofficial side effect to the medication’s more official side effects, like gastrointestinal distress and dehydration. And, this year, the rise of “Ozempic breath” has gotten so bad that it’s starting to show up in market data.cnx.cmd.push(function(){cnx({"playerId":"92b7b46b-43ed-4e0e-b21b-2c999302d9d7","settings":{"advertising":{"macros":{"AD_UNIT":"/23178111854/od.gizmodo.com/article","CHILD_UNIT":"article","POST_ID":"2000753320","POST_TYPE":"post","CHANNEL":"science","SECTION":"health","SUBSECTION":"","CATEGORIES":"health","TAGS":"glp-1s,ozempic,ozempic-breath,wegovy","NOP":"0"},"timeBeforeFirstAd":0}}}).render("cnx-player-main")}); Hershey CEO Kirk Tanner told investors on…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Gizmodo.
Discussion
0 commentsMore from Gizmodo
